These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 24344159)

  • 1. Prevalence of Raynaud phenomenon in the general population. A preliminary study by questionnaire.
    Maricq HR; Weinrich MC; Keil JE; LeRoy EC
    J Chronic Dis; 1986; 39(6):423-7. PubMed ID: 3711250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study.
    Hasegawa M; Asano Y; Endo H; Fujimoto M; Goto D; Ihn H; Inoue K; Ishikawa O; Kawaguchi Y; Kuwana M; Ogawa F; Takahashi H; Tanaka S; Sato S; Takehara K
    PLoS One; 2014; 9(2):e88150. PubMed ID: 24516598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of plasma identifies the Toll-like receptor agonists S100A8/A9 as a novel possible marker for systemic sclerosis phenotype.
    van Bon L; Cossu M; Loof A; Gohar F; Wittkowski H; Vonk M; Roth J; van den Berg W; van Heerde W; Broen JC; Radstake TR
    Ann Rheum Dis; 2014 Aug; 73(8):1585-9. PubMed ID: 24718960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum amyloid A is a marker for pulmonary involvement in systemic sclerosis.
    Lakota K; Carns M; Podlusky S; Mrak-Poljsak K; Hinchcliff M; Lee J; Tomsic M; Sodin-Semrl S; Varga J
    PLoS One; 2015; 10(1):e0110820. PubMed ID: 25629975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New potential biomarkers for disease activity and fibrosis in systemic sclerosis.
    Vadasz Z; Rimar D
    Isr Med Assoc J; 2014 Oct; 16(10):629-30. PubMed ID: 25438451
    [No Abstract]   [Full Text] [Related]  

  • 6. Systemic sclerosis biomarkers discovered using mass-spectrometry-based proteomics: a systematic review.
    Bălănescu P; Lădaru A; Bălănescu E; Băicuş C; Dan GA
    Biomarkers; 2014 Aug; 19(5):345-55. PubMed ID: 24831309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caveolin-1 deficiency may predispose African Americans to systemic sclerosis-related interstitial lung disease.
    Reese C; Perry B; Heywood J; Bonner M; Visconti RP; Lee R; Hatfield CM; Silver RM; Hoffman S; Tourkina E
    Arthritis Rheumatol; 2014 Jul; 66(7):1909-19. PubMed ID: 24578173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brief report: lysyl oxidase is a potential biomarker of fibrosis in systemic sclerosis.
    Rimar D; Rosner I; Nov Y; Slobodin G; Rozenbaum M; Halasz K; Haj T; Jiries N; Kaly L; Boulman N; Daood R; Vadasz Z
    Arthritis Rheumatol; 2014 Mar; 66(3):726-30. PubMed ID: 24574233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Interferon- and transforming growth factor β-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis.
    Christmann RB; Sampaio-Barros P; Stifano G; Borges CL; de Carvalho CR; Kairalla R; Parra ER; Spira A; Simms R; Capellozzi VL; Lafyatis R
    Arthritis Rheumatol; 2014 Mar; 66(3):714-25. PubMed ID: 24574232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development.
    Lambrecht S; Smith V; De Wilde K; Coudenys J; Decuman S; Deforce D; De Keyser F; Elewaut D
    Arthritis Rheumatol; 2014 Feb; 66(2):418-27. PubMed ID: 24504814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2X7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosus.
    Faliti CE; Gualtierotti R; Rottoli E; Gerosa M; Perruzza L; Romagnani A; Pellegrini G; De Ponte Conti B; Rossi RL; Idzko M; Mazza EMC; Bicciato S; Traggiai E; Meroni PL; Grassi F
    J Exp Med; 2019 Feb; 216(2):317-336. PubMed ID: 30655308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current perspective on rituximab in rheumatic diseases.
    Schioppo T; Ingegnoli F
    Drug Des Devel Ther; 2017; 11():2891-2904. PubMed ID: 29042750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on juvenile systemic sclerosis.
    Foeldvari I
    Curr Rheumatol Rep; 2015 Mar; 17(3):18. PubMed ID: 25761925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrosis biomarkers in isolated Raynaud's phenomenon: too little, too soon?
    Ingegnoli F; Gualtierotti R; Schioppo T; Orenti A; Boracchi P; Lubatti C; Mastaglio C; Galbiati V; Murgo A; Zeni S; Grossi C; Borghi O; Rosenberg W; Castelnovo L; Meroni Pier L
    Ann Rheum Dis; 2014 May; 73(5):940-1. PubMed ID: 24344159
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon.
    Seibold JR; Harris JN
    J Rheumatol; 1985 Feb; 12(1):99-103. PubMed ID: 2580093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low plasma protein nitrotyrosine levels distinguish primary Raynaud's phenomenon from scleroderma.
    Kingdon EJ; Mani AR; Frost MT; Denton CP; Powis SH; Black CM; Moore KP
    Ann Rheum Dis; 2006 Jul; 65(7):952-4. PubMed ID: 16308344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in red cell behaviour between patients with Raynaud's phenomenon and systemic sclerosis and patients with Raynaud's disease.
    Rustin MH; Kovacs IB; Sowemimo-Coker SO; Maddison PJ; Kirby JD
    Br J Dermatol; 1985 Sep; 113(3):265-72. PubMed ID: 3877518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications from capillaroscopic analysis in patients with Raynaud's phenomenon and systemic sclerosis.
    Herrick AL; Cutolo M
    Arthritis Rheum; 2010 Sep; 62(9):2595-604. PubMed ID: 20506306
    [No Abstract]   [Full Text] [Related]  

  • 19. Raynaud's phenomenon, scleroderma, overlap syndromes, and other fibrosing syndromes.
    Clements PJ
    Curr Opin Rheumatol; 1994 Nov; 6(6):603-6. PubMed ID: 7865380
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.